| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Hyoscine methylbromide |
Is a |
False |
Methscopolamine (substance) |
Inferred relationship |
Some |
|
| Product containing methscopolamine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Methscopolamine (substance) |
Inferred relationship |
Some |
1 |
| Chlorpheniramine maleate + methscopolamine nitrate + pseudoephedrine hydrochloride 8mg/2.5mg/120mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methscopolamine (substance) |
Inferred relationship |
Some |
|
| Methscopolamine 2.5 mg and pseudoephedrine hydrochloride 120 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methscopolamine (substance) |
Inferred relationship |
Some |
|
| Methscopolamine m/r |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methscopolamine (substance) |
Inferred relationship |
Some |
|
| Product containing methscopolamine and pseudoephedrine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methscopolamine (substance) |
Inferred relationship |
Some |
|
| Chlorpheniramine maleate + methscopolamine nitrate + pseudoephedrine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methscopolamine (substance) |
Inferred relationship |
Some |
|
| Product containing precisely methscopolamine 5 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methscopolamine (substance) |
Inferred relationship |
Some |
|
| Methscopolamine nitrate (substance) |
Is a |
False |
Methscopolamine (substance) |
Inferred relationship |
Some |
|
| Product containing precisely methscopolamine 5 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methscopolamine (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely methscopolamine 5 milligram/1 each conventional release oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Methscopolamine (substance) |
Inferred relationship |
Some |
1 |
| Methscopolamine 2.5 mg and pseudoephedrine hydrochloride 120 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methscopolamine (substance) |
Inferred relationship |
Some |
1 |
| Methscopolamine 2.5 mg and pseudoephedrine hydrochloride 120 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Methscopolamine (substance) |
Inferred relationship |
Some |
1 |
| Methscopolamine nitrate (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Methscopolamine (substance) |
Inferred relationship |
Some |
|
| Hyoscine methylbromide |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Methscopolamine (substance) |
Inferred relationship |
Some |
|
| Chlorpheniramine maleate + methscopolamine nitrate + pseudoephedrine hydrochloride 8mg/2.5mg/120mg prolonged-release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methscopolamine (substance) |
Inferred relationship |
Some |
|
| Product containing precisely methscopolamine 5 milligram/1 each conventional release oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Methscopolamine (substance) |
Inferred relationship |
Some |
1 |
| Methscopolamine 2.5 mg and pseudoephedrine hydrochloride 120 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Methscopolamine (substance) |
Inferred relationship |
Some |
1 |
| Product containing methscopolamine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Methscopolamine (substance) |
Inferred relationship |
Some |
1 |
| Methscopolamine- and pseudoephedrine-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Methscopolamine (substance) |
Inferred relationship |
Some |
1 |
| Product containing methscopolamine and pseudoephedrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Methscopolamine (substance) |
Inferred relationship |
Some |
1 |
| Product containing only methscopolamine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Methscopolamine (substance) |
Inferred relationship |
Some |
1 |
| Methscopolamine and pseudoephedrine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Methscopolamine (substance) |
Inferred relationship |
Some |
1 |
| Product containing only methscopolamine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Methscopolamine (substance) |
Inferred relationship |
Some |
1 |
| Methscopolamine and pseudoephedrine only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Methscopolamine (substance) |
Inferred relationship |
Some |
1 |
| Chlorphenamine- and methscopolamine- and pseudoephedrine-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Methscopolamine (substance) |
Inferred relationship |
Some |
1 |
| Chlorphenamine and methscopolamine and pseudoephedrine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Methscopolamine (substance) |
Inferred relationship |
Some |
1 |
| Product containing only chlorphenamine and methscopolamine and pseudoephedrine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Methscopolamine (substance) |
Inferred relationship |
Some |
1 |
| Product containing chlorphenamine and methscopolamine and pseudoephedrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Methscopolamine (substance) |
Inferred relationship |
Some |
1 |
| Methscopolamine 2.5 mg and pseudoephedrine hydrochloride 120 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Methscopolamine (substance) |
Inferred relationship |
Some |
2 |
| Methscopolamine 2.5 mg and pseudoephedrine hydrochloride 120 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Methscopolamine (substance) |
Inferred relationship |
Some |
2 |
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.22-SNAPSHOT
|
FHIR Version n/a
User: [n/a]